Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ex Vivo Immunogenicity Screening of Vaccine Candidate Antigen Combinations in Ethiopian Patients With Visceral and Cutaneous Leishmaniasis

NCT07783243 is registered in ClinicalTrials.gov with Institute of Tropical Medicine, Belgium as lead sponsor.

NCT NCT07783243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07783243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ex Vivo Immunogenicity Screening of Vaccine Candidate Antigen Combinations in Ethiopian Patients With Visceral and Cutaneous Leishmaniasis
Lead sponsor
Institute of Tropical Medicine, Belgium
Phase
Observational
Overall status
Recruiting
Start date
May 26, 2026
Completion date
December 31, 2026
Enrollment
90 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

immunogenicity, leishmaniasis, leishmaniasis, cutaneous, leishmaniasis, visceral